Skip to content
Home
Investors
Company Information
Press Releases
SEC Filings
Stock Data
Research Coverage
Contact
Menu
Home
Investors
Company Information
Press Releases
SEC Filings
Stock Data
Research Coverage
Contact
Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster's Campaign Against the Company (12.17.21)
×